YCBD - cbdMD releases cannabinoid therapeutics research plan

cbdMD ([[YCBD]] +0.8%) announces that its recently formed division, cbdMD Therapeutics, has initiated talks with one of the leading US cannabinoid research institutes, to identify novel cannabinoids for therapeutic use.The company also anticipates the identification of dietary supplement applications through this process.Expects to finalize the agreement with the research institute and commence studies by Fall 2021.cbdMD Therapeutics will perform requisite toxicological studies with Ion Tox, a leading in vitro toxicology and ADME-PK testing company, to support the safety of the cannabinoids.The company had announced a collaboration to study its cannabinoid blend on dogs with osteoarthritis, last month.

For further details see:

cbdMD releases cannabinoid therapeutics research plan